An algorithm for discontinuing mechanical ventilation in boys with x-linked myotubular myopathy after positive response to gene therapy: the ASPIRO experience.


Journal

Respiratory research
ISSN: 1465-993X
Titre abrégé: Respir Res
Pays: England
ID NLM: 101090633

Informations de publication

Date de publication:
16 Sep 2024
Historique:
received: 13 02 2024
accepted: 02 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

X-linked myotubular myopathy (XLMTM) is a rare, life-threatening congenital myopathy. Most (80%) children with XLMTM have profound muscle weakness and hypotonia at birth resulting in severe respiratory insufficiency, the inability to sit up, stand or walk, and early mortality. At birth, 85-90% of children with XLMTM require mechanical ventilation, with more than half requiring invasive ventilator support. Historically, ventilator-dependent children with neuromuscular-derived respiratory failure of this degree and nature, static or progressive, are not expected to achieve complete independence from mechanical ventilator support. In the ASPIRO clinical trial (NCT03199469), participants receiving a single intravenous dose of an investigational gene therapy (resamirigene bilparvovec) started showing significant improvements in daily hours of ventilation support compared with controls by 24 weeks post-dosing, and 16 of 24 dosed participants achieved ventilator independence between 14 and 97 weeks after dosing. At the time, there was no precedent or published guidance for weaning chronically ventilated children with congenital neuromuscular diseases off mechanical ventilation. When the first ASPIRO participants started showing dramatically improved respiratory function, the investigators initiated efforts to safely wean them off ventilator support, in parallel with primary protocol respiratory outcome measures. A group of experts in respiratory care and physiology and management of children with XLMTM developed an algorithm to safely wean children in the ASPIRO trial off mechanical ventilation as their respiratory muscle strength increased. The algorithm developed for this trial provides recommendations for assessing weaning readiness, a stepwise approach to weaning, and monitoring of children during and after the weaning process.

Identifiants

pubmed: 39285418
doi: 10.1186/s12931-024-02966-0
pii: 10.1186/s12931-024-02966-0
doi:

Types de publication

Journal Article Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

342

Informations de copyright

© 2024. The Author(s).

Références

Boles JM, Bion J, Connors A, Herridge M, Marsh B, Melot C, Pearl R, Silverman H, Stanchina M, Vieillard-Baron A, Welte T. Weaning from mechanical ventilation. Eur Respir J. 2007;29(5):1033–56.
pubmed: 17470624 doi: 10.1183/09031936.00010206
McConville JF, Kress JP. Weaning patients from the ventilator. N Engl J Med. 2012;367(23):2233–9.
pubmed: 23215559 doi: 10.1056/NEJMra1203367
Henningfeld JK, Maletta K, Ren B, Richards KL, Wegner C, D’Andrea LA. Liberation from home mechanical ventilation and decannulation in children. Pediatr Pulmonol. 2016;51(8):838–49.
pubmed: 26934657 doi: 10.1002/ppul.23396
Gundogdu I, Ozturk EA, Umay E, Karaahmet OZ, Unlu E, Cakci A. Implementation of a respiratory rehabilitation protocol: weaning from the ventilator and tracheostomy in difficult-to-wean patients with spinal cord injury. Disabil Rehabil. 2017;39(12):1162–70.
pubmed: 27339104 doi: 10.1080/09638288.2016.1189607
Gutierrez CJ, Harrow J, Haines F. Using an evidence-based protocol to guide rehabilitation and weaning of ventilator-dependent cervical spinal cord injury patients. J Rehabil Res Dev. 2003;40(5 Suppl 2):99–110.
pubmed: 15074456 doi: 10.1682/JRRD.2003.10.0099
Gutierrez CJ, Stevens C, Merritt J, Pope C, Tanasescu M, Curtiss G. Trendelenburg chest optimization prolongs spontaneous breathing trials in ventilator-dependent patients with low cervical spinal cord injury. J Rehabil Res Dev. 2010;47(3):261–72.
pubmed: 20665351 doi: 10.1682/JRRD.2009.07.0099
Khemani RG, Sekayan T, Hotz J, Flink RC, Rafferty GF, Iyer N, Newth CJL. Risk factors for Pediatric Extubation failure: the importance of respiratory muscle strength. Crit Care Med. 2017;45(8):e798–805.
pubmed: 28437378 pmcid: 5511064 doi: 10.1097/CCM.0000000000002433
Emeriaud G, Larouche A, Ducharme-Crevier L, Massicotte E, Flechelles O, Pellerin-Leblanc AA, Morneau S, Beck J, Jouvet P. Evolution of inspiratory diaphragm activity in children over the course of the PICU stay. Intensive Care Med. 2014;40(11):1718–26.
pubmed: 25118865 doi: 10.1007/s00134-014-3431-4
Harikumar G, Egberongbe Y, Nadel S, Wheatley E, Moxham J, Greenough A, Rafferty GF. Tension-time index as a predictor of extubation outcome in ventilated children. Am J Respir Crit Care Med. 2009;180(10):982–8.
pubmed: 19696443 pmcid: 2778157 doi: 10.1164/rccm.200811-1725OC
Manczur TI, Greenough A, Pryor D, Rafferty GF. Assessment of respiratory drive and muscle function in the pediatric intensive care unit and prediction of extubation failure. Pediatr Crit Care Med. 2000;1(2):124–6.
pubmed: 12813262 doi: 10.1097/00130478-200010000-00006
Wolf GK, Walsh BK, Green ML, Arnold JH. Electrical activity of the diaphragm during extubation readiness testing in critically ill children. Pediatr Crit Care Med. 2011;12(6):e220–4.
pubmed: 21057368 doi: 10.1097/PCC.0b013e3181fe28fc
Gupta R, Rosen D. Paediatric mechanical ventilation in the intensive care unit. BJA Educ. 2016;16(12):422–6.
doi: 10.1093/bjaed/mkw025
Cristea AI, Carroll AE, Davis SD, Swigonski NL, Ackerman VL. Outcomes of children with severe bronchopulmonary dysplasia who were ventilator dependent at home. Pediatrics. 2013;132(3):e727–34.
pubmed: 23918888 pmcid: 3876749 doi: 10.1542/peds.2012-2990
Panagiotou P, Kanaka-Gantenbein C, Kaditis AG. Changes in ventilatory support requirements of spinal muscular atrophy (SMA) patients Post Gene-based therapies. Child (Basel). 2022;9(8).
Keller C, Reynolds A, Lee B, Garcia-Prats J. Congenital myotonic dystrophy requiring prolonged endotracheal and noninvasive assisted ventilation: not a uniformly fatal condition. Pediatrics. 1998;101(4 Pt 1):704–6.
pubmed: 9521960 doi: 10.1542/peds.101.4.704
Bach JR, Niranjan V, Weaver B. Spinal muscular atrophy type 1: a noninvasive respiratory management approach. Chest. 2000;117(4):1100–5.
pubmed: 10767247 doi: 10.1378/chest.117.4.1100
Bach JR, Martinez D. Duchenne muscular dystrophy: continuous noninvasive ventilatory support prolongs survival. Respir Care. 2011;56(6):744–50.
pubmed: 21333078 doi: 10.4187/respcare.00831
Bach JR, Chiou M, Saporito LR, Esquinas AM. Evidence-based Medicine Analysis of Mechanical Insufflation-Exsufflation devices. Respir Care. 2017;62(5):643.
pubmed: 28442593 doi: 10.4187/respcare.05535
Lee J, Park SE, Lee D, Song JY, Lee J. Successful weaning from mechanical ventilation in a patient with SMA type 1 treated with nusinersen. Ann Clin Transl Neurol. 2021;8(4):964–7.
pubmed: 33616311 pmcid: 8045896 doi: 10.1002/acn3.51321
Amburgey K, Tsuchiya E, de Chastonay S, Glueck M, Alverez R, Nguyen CT, Rutkowski A, Hornyak J, Beggs AH, Dowling JJ. A natural history study of X-linked myotubular myopathy. Neurology. 2017;89(13):1355–64.
pubmed: 28842446 pmcid: 5649758 doi: 10.1212/WNL.0000000000004415
Annoussamy M, Lilien C, Gidaro T, Gargaun E, Che V, Schara U, Gangfuss A, D’Amico A, Dowling JJ, Darras BT, Daron A, Hernandez A, de Lattre C, Arnal JM, Mayer M, Cuisset JM, Vuillerot C, Fontaine S, Bellance R, Biancalana V, Buj-Bello A, Hogrel JY, Landy H, Servais L. X-linked myotubular myopathy: a prospective international natural history study. Neurology. 2019;92(16):e1852–67.
pubmed: 30902907 pmcid: 6550499 doi: 10.1212/WNL.0000000000007319
Beggs AH, Byrne BJ, De Chastonay S, Haselkorn T, Hughes I, James ES, Kuntz NL, Simon J, Swanson LC, Yang ML, Yu ZF, Yum SW, Prasad S. A multicenter, retrospective medical record review of X-linked myotubular myopathy: the RECENSUS study. Muscle Nerve. 2018;57(4):550–60.
pubmed: 29149770 doi: 10.1002/mus.26018
McEntagart M, Parsons G, Buj-Bello A, Biancalana V, Fenton I, Little M, Krawczak M, Thomas N, Herman G, Clarke A, Wallgren-Pettersson C. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord. 2002;12(10):939–46.
pubmed: 12467749 doi: 10.1016/S0960-8966(02)00153-0
Graham RJ, Muntoni F, Hughes I, Yum SW, Kuntz NL, Yang ML, Byrne BJ, Prasad S, Alvarez R, Genetti CA, Haselkorn T, James ES, LaRusso LB, Noursalehi M, Rico S, Beggs AH. Mortality and respiratory support in X-linked myotubular myopathy: a RECENSUS retrospective analysis. Arch Dis Child. 2019.
Herman GE, Finegold M, Zhao W, de Gouyon B, Metzenberg A. Medical complications in long-term survivors with X-linked myotubular myopathy. J Pediatr. 1999;134(2):206–14.
pubmed: 9931531 doi: 10.1016/S0022-3476(99)70417-8
Dowling JJ, Muller-Felber W, Smith BK, Bonnemann CG, Kuntz NL, Muntoni F, Servais L, Alfano LN, Beggs AH, Bilder DA, Blaschek A, Duong T, Graham RJ, Jain M, Lawlor MW, Lee J, Coats J, Lilien C, Lowes LP, MacBean V, Neuhaus S, Noursalehi M, Pitts T, Finlay C, Christensen S, Rafferty G, Seferian AM, Tsuchiya E, James ES, Miller W, Sepulveda B, Vila MC, Prasad S, Rico S, Shieh PB. Investigators I. INCEPTUS Natural History, run-in study for gene replacement clinical trial in X-Linked Myotubular Myopathy. J Neuromuscul Dis. 2022;9(4):503–16.
pubmed: 35694931 pmcid: 9398079 doi: 10.3233/JND-210781
Shieh PB, Kuntz NL, Dowling JJ, Muller-Felber W, Bonnemann CG, Seferian AM, Servais L, Smith BK, Muntoni F, Blaschek A, Foley AR, Saade DN, Neuhaus S, Alfano LN, Beggs AH, Buj-Bello A, Childers MK, Duong T, Graham RJ, Jain M, Coats J, MacBean V, James ES, Lee J, Mavilio F, Miller W, Varfaj F, Murtagh M, Han C, Noursalehi M, Lawlor MW, Prasad S, Rico S. Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trial. Lancet Neurol. 2023;22(12):1125–39.
pubmed: 37977713 doi: 10.1016/S1474-4422(23)00313-7
Amaddeo A, Frapin A, Fauroux B. Long-term non-invasive ventilation in children. Lancet Respir Med. 2016;4(12):999–1008.
pubmed: 27423917 doi: 10.1016/S2213-2600(16)30151-5
Kallenbach SL, Espahbodi M, Amos LB, Beste DJ, Chun RH. Primary tracheocutaneous fistula closure with immediate transition to nocturnal noninvasive positive pressure ventilation in two children with congenital Central Hypoventilation Syndrome. Int J Pediatr Otorhinolaryngol. 2020;134:110019.
pubmed: 32247940 doi: 10.1016/j.ijporl.2020.110019
Crimi C, Pierucci P, Carlucci A, Cortegiani A, Gregoretti C. Long-term ventilation in neuromuscular patients: review of concerns, beliefs, and ethical dilemmas. Respiration. 2019;97(3):185–96.
pubmed: 30677752 doi: 10.1159/000495941
Simonds AK. Home ventilation. Eur Respir J Suppl. 2003;47:s38–46.
doi: 10.1183/09031936.03.00029803
Benditt JO, Boitano LJ. Pulmonary issues in patients with chronic neuromuscular disease. Am J Respir Crit Care Med. 2013;187(10):1046–55.
pubmed: 23590262 doi: 10.1164/rccm.201210-1804CI
Panitch HB. Respiratory issues in the management of children with neuromuscular disease. Respir Care. 2006;51(8):885–93. discussion 94 – 5.
pubmed: 16867199
Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in Primary Care: a Population-based Cohort Study. PLoS Med. 2016;13(5):e1002024.
pubmed: 27218256 pmcid: 4878789 doi: 10.1371/journal.pmed.1002024
Epstein SK, Walkey A. Methods of weaning from mechanical ventilation. UpToDate, Inc [Internet]. 2018 August 1, 2018. www.uptodate.com
Newth CJ, Venkataraman S, Willson DF, Meert KL, Harrison R, Dean JM, Pollack M, Zimmerman J, Anand KJ, Carcillo JA, Nicholson CE. Eunice Shriver Kennedy National Institute of Child H, Human Development Collaborative Pediatric Critical Care Research N. Weaning and extubation readiness in pediatric patients. Pediatr Crit Care Med. 2009;10(1):1–11.
pubmed: 19057432 pmcid: 2849975 doi: 10.1097/PCC.0b013e318193724d
Johnson DC, Campbell SL, Rabkin JD. Tracheostomy tube manometry: evaluation of speaking valves, capping and need for downsizing. Clin Respir J. 2009;3(1):8–14.
pubmed: 20298366 doi: 10.1111/j.1752-699X.2008.00100.x
Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J, Gibson N, Gordon J, Hughes I, McCulloch R, Russell RR, Simonds A. British thoracic society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67(Suppl 1):i1–40.
pubmed: 22730428 doi: 10.1136/thoraxjnl-2012-201964
Foster CC, Kwon S, Shah AV, Hodgson CA, Hird-McCorry LP, Janus A, Jedraszko AM, Swanson P, Davis MM, Goodman DM, Laguna TA. At-home end-tidal carbon dioxide measurement in children with invasive home mechanical ventilation. Pediatr Pulmonol. 2022;57(11):2735–44.
pubmed: 35959530 pmcid: 9588689 doi: 10.1002/ppul.26092
Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018;17(4):347–61.
pubmed: 29395990 pmcid: 5889091 doi: 10.1016/S1474-4422(18)30025-5
Gurbani N, Pascoe JE, Katz S, Sawnani H. Sleep disordered breathing: Assessment and therapy in the age of emerging neuromuscular therapies. Pediatr Pulmonol. 2020.
Duong T, Harding G, Mannix S, Abel C, Phillips D, Alfano LN, Bonnemann CG, Lilien C, Lowes L, Servais L, Warken-Madelung B, Nieto Bergman S, James E, Noursalehi M, Prasad S, Rico S, Bilder D. Use of the Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) in X-Linked Myotubular Myopathy: Content Validity and Psychometric Performance. J Neuromuscul Dis. 2020.
de Lattre C, Payan C, Vuillerot C, Rippert P, de Castro D, Berard C, Poirot I, Group MFMS. Motor function measure: validation of a short form for young children with neuromuscular diseases. Arch Phys Med Rehabil. 2013;94(11):2218–26.
pubmed: 23602884 doi: 10.1016/j.apmr.2013.04.001
Bayley N. Bayley Scales of Infant and Toddler Development. Third ed. San Antonio, TX: Harcourt Assessment; 2006.
Cristea AI, Baker CD. Ventilator weaning and tracheostomy decannulation in children: more than one way. Pediatr Pulmonol. 2016;51(8):773–4.
pubmed: 27061157 pmcid: 5081685 doi: 10.1002/ppul.23418
Cristea AI, Jalou HE, Givan DC, Davis SD, Slaven JE, Ackerman VL. Use of polysomnography to assess safe decannulation in children. Pediatr Pulmonol. 2016;51(8):796–802.
pubmed: 26919704 doi: 10.1002/ppul.23395
Kennedy A, Hart CK, de Alarcon A, Balakrishnan K, Boudewyns A, Chun R, Fayoux P, Goudy SL, Hartnick C, Hsu WC, Johnson RF, Kuo M, Peer S, Pransky SM, Rahbar R, Rickert S, Roy S, Russell J, Sandu K, Sidell DR, Smith RJ, Soma M, Spratley J, Thierry B, Thompson DM, Trozzi M, Watters K, White DR, Wyatt M, Zalzal GH, Zdanksi CJ, Zur KB, Rutter MJ. International Pediatric Otolaryngology Group (IPOG) management recommendations: Pediatric tracheostomy decannulation. Int J Pediatr Otorhinolaryngol. 2021;141:110565.
pubmed: 33341719 doi: 10.1016/j.ijporl.2020.110565
Raynor T, Bedwell J. Pediatric tracheostomy decannulation: what’s the evidence? Curr Opin Otolaryngol Head Neck Surg. 2023;31(6):397–402.
pubmed: 37751378 doi: 10.1097/MOO.0000000000000929
Albdewi MA, Liistro G, El Tahry R. Sleep-disordered breathing in patients with neuromuscular disease. Sleep Breath. 2018;22(2):277–86.
pubmed: 28702830 doi: 10.1007/s11325-017-1538-x
Gibson B. Long-term ventilation for patients with Duchenne muscular dystrophy: physicians’ beliefs and practices. Chest. 2001;119(3):940–6.
pubmed: 11243978 doi: 10.1378/chest.119.3.940
Hardart MK, Burns JP, Truog RD. Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes. Pediatrics. 2002;110(2 Pt 1):e24.
pubmed: 12165623 doi: 10.1542/peds.110.2.e24
Kinali M, Manzur AY, Mercuri E, Gibson BE, Hartley L, Simonds AK, Muntoni F. UK physicians’ attitudes and practices in long-term non-invasive ventilation of Duchenne muscular dystrophy. Pediatr Rehabil. 2006;9(4):351–64.
pubmed: 17111551 doi: 10.1080/13638490600622613
Birnkrant DJ, Panitch HB, Benditt JO, Boitano LJ, Carter ER, Cwik VA, Finder JD, Iannaccone ST, Jacobson LE, Kohn GL, Motoyama EK, Moxley RT, Schroth MK, Sharma GD, Sussman MD. American College of Chest Physicians consensus statement on the respiratory and related management of patients with Duchenne muscular dystrophy undergoing anesthesia or sedation. Chest. 2007;132(6):1977–86.
pubmed: 18079231 doi: 10.1378/chest.07-0458
Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, Kovesi T, Kravitz RM, Panitch H, Schramm C, Schroth M, Sharma G, Sievers L, Silvestri JM, Sterni L. American thoracic S. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med. 2004;170(4):456–65.
pubmed: 15302625 doi: 10.1164/rccm.200307-885ST
Finkel RS, Mercuri E, Meyer OH, Simonds AK, Schroth MK, Graham RJ, Kirschner J, Iannaccone ST, Crawford TO, Woods S, Muntoni F, Wirth B, Montes J, Main M, Mazzone ES, Vitale M, Snyder B, Quijano-Roy S, Bertini E, Davis RH, Qian Y, Sejersen T. group SMAC. Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics. Neuromuscul Disord. 2018;28(3):197–207.

Auteurs

Robert J Graham (RJ)

Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.

Reshma Amin (R)

Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Nadir Demirel (N)

Mayo Clinic, Rochester, MN, USA.

Lisa Edel (L)

Great Ormond Street Hospital for Children London, London, UK.

Charlotte Lilien (C)

MDUK Oxford Neuromuscular Centre, Oxford, UK.
Institute I-Motion, Hôpital Armand Trousseau, Paris, France.

Victoria MacBean (V)

Brunel University London, London, UK.

Gerrard F Rafferty (GF)

King's College London, London, UK.

Hemant Sawnani (H)

Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
University of Cincinnati, Cincinnati College of Medicine, Cincinnati, OH, USA.

Carola Schön (C)

Hauner's Children's Hospital, University of Munich, Munich, Germany.

Barbara K Smith (BK)

University of Florida, Gainesville, FL, USA.

Faiza Syed (F)

Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.

Micaela Sarazen (M)

Formerly of Astellas Gene Therapies, San Francisco, CA, USA.

Suyash Prasad (S)

Formerly of Astellas Gene Therapies, San Francisco, CA, USA.

Salvador Rico (S)

Formerly of Astellas Gene Therapies, San Francisco, CA, USA.

Geovanny F Perez (GF)

Oishei Children's Hospital, Jacobs School of Medicine and Biomedical Sciences, Oishei Children's Hospital University at Buffalo, Buffalo, NY, USA. gperez@upa.chob.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH